These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27843229)

  • 21. A single intraoperative sub-tenon's capsule injection of triamcinolone and ciprofloxacin in a controlled-release system for cataract surgery.
    Paganelli F; Cardillo JA; Melo LA; Lucena DR; Silva AA; Oliveira AG; Höfling-Lima AL; Nguyen QD; Kuppermann BD; Belfort R;
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3041-7. PubMed ID: 19234342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of topical steroids vs nonsteroidal anti-inflammatory drugs to control postcataract surgery inflammation.
    Deka A
    J Cataract Refract Surg; 2020 Oct; 46(10):1397-1401. PubMed ID: 32590482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site.
    Cable M
    Clin Ophthalmol; 2012; 6():997-1004. PubMed ID: 22815642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracameral triamcinolone acetonide to control postoperative inflammation following cataract surgery with phacoemulsification.
    Karalezli A; Borazan M; Akova YA
    Acta Ophthalmol; 2008 Mar; 86(2):183-7. PubMed ID: 18162061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized clinical trial of Surodex steroid drug delivery system for cataract surgery: anterior versus posterior placement of two Surodex in the eye.
    Tan DT; Chee SP; Lim L; Theng J; Van Ede M
    Ophthalmology; 2001 Dec; 108(12):2172-81. PubMed ID: 11733254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
    Hirneiss C; Neubauer AS; Kampik A; Schönfeld CL
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):768-73. PubMed ID: 15756571
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison between 0.1% Nepafenac and 1% Prednisolone Eye Drop in Postoperative Management Following Micro-incisional Cataract Surgery.
    Sarkar S; Bardoloi N; Deb AK
    Korean J Ophthalmol; 2021 Jun; 35(3):188-197. PubMed ID: 34120417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study.
    Solomon KD; Vroman DT; Barker D; Gehlken J
    J Cataract Refract Surg; 2001 Aug; 27(8):1232-7. PubMed ID: 11524195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. To Study the Efficacy of Difluprednate Ophthalmic Emulsion and Prednisolone Acetate Ophthalmic Suspension on Post-operative Inflammation in Cataract Surgery.
    Garg P; Tuteja N; Qayum S
    J Clin Diagn Res; 2016 Dec; 10(12):NC05-NC08. PubMed ID: 28208898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP; Solomon KD; Sandoval HP; Vroman DT
    J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of bromfenac ophthalmic solution (Bromday) dosed once daily for postoperative ocular inflammation and pain.
    Henderson BA; Gayton JL; Chandler SP; Gow JA; Klier SM; McNamara TR;
    Ophthalmology; 2011 Nov; 118(11):2120-7. PubMed ID: 21762992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation.
    Tan DT; Chee SP; Lim L; Lim AS
    Ophthalmology; 1999 Feb; 106(2):223-31. PubMed ID: 9951469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
    Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of 0.1% dexamethasone phosphate eye gel (Dexagel) and 1% prednisolone acetate eye suspension in the treatment of post-operative inflammation after cataract surgery.
    Struck HG; Bariszlovich A
    Graefes Arch Clin Exp Ophthalmol; 2001 Oct; 239(10):737-42. PubMed ID: 11760033
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of topical 0.7% dexamethasone-cyclodextrin with 0.1% dexamethasone sodium phosphate for postcataract inflammation.
    Saari KM; Nelimarkka L; Ahola V; Loftsson T; Stefánsson E
    Graefes Arch Clin Exp Ophthalmol; 2006 May; 244(5):620-6. PubMed ID: 16217662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II results of an intraocular steroid delivery system for cataract surgery.
    Chang DF; Garcia IH; Hunkeler JD; Minas T
    Ophthalmology; 1999 Jun; 106(6):1172-7. PubMed ID: 10366088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
    el-Harazi SM; Ruiz RS; Feldman RM; Villanueva G; Chuang AZ
    Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV; Westfield KC; Chalkley TH
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ketorolac-tobramycin combination vs fluorometholone-tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision.
    Guzey M; Karadede S; Dogan Z; Satici A
    Ophthalmic Surg Lasers; 2000; 31(6):451-6. PubMed ID: 11095120
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal.
    Brookshire HL; English RV; Nadelstein B; Weigt AK; Gift BW; Gilger BC
    Vet Ophthalmol; 2015 May; 18(3):175-85. PubMed ID: 24636042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.